Company profilePharmaceutical#381 of 1,318 in Pakistan✓ No DRAP alerts

LEXICON PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 44 brands · 54 molecules

Ranked #16 of 31 companies in Antifungal For Dermatological

44 registered products 17 pharmaceutical brands 54 distinct molecules 0 DRAP alerts

Company overview

44
registered products
17
pharmaceutical brands
54
distinct molecules
2
therapeutic classes
0
DRAP alerts

LEXICON PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 44 product registrations across 54 distinct molecules. Its portfolio is concentrated in Antifungal For Dermatological and Angiotensin-Ii Antagonists, Combinations. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by LEXICON

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

1
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20261

Top molecules by brand count

Therapeutic classes

Antifungal For Dermatological · 1Angiotensin-Ii Antagonists, Combinations · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official6 products · Rs 85.13 – Rs 1,195.49
DVAGO2 products · Rs 94.99 – Rs 247.45
Median across source: Rs 282.94

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 132 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin
NEUTRO PHARMA (PVT) LTD. holds 127 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAmikacinAnastrazoleAnastrozole
VALOR PHARMACEUTICALS holds 159 molecules not in this portfolio
000 I.UAcetylcysteineAcitretinAcyclovirAdapaleneAdaplene

Get the full profile for LEXICON

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.